Initially considered as genomic “junk”, long noncoding RNAs have gained attention as critical regulators of coding RNA and alternative splicing. LncRNAs have been associated with tumorigenesis, tumor progression and metastasis, thus emerging as a new class of promising cancer biomarkers and targets for therapeutic agents.

In this webinar, the speakers will:

  • Demonstrate how transcriptome profiling can identify lncRNAs and novel cancer biomarkers
  • Explain the role of lncRNAs in breast cancer progression and tumorigenesis


  • Rebecca DeVaux, PhD, University at Albany State University of New York, USA
  • Alfredo Hidalgo-Miranda, PhD, National Institute of Genomic Medicine, Mexico

Click on the button to view the on-demand webinar


I would like to receive information about events, products, services and promotions from Thermo Fisher Scientific and its affiliates.

 By email
 By telephone

By following relevant data privacy laws, Thermo Fisher Scientific will take great care in processing my personal data in line with its privacy policy, which can be reviewed at thermofisher.com/privacypolicy.